For example, hepatic expression of fatty acid translocase CD36 is markedly increased in subjects with NAFLD, and hepatic expression of FABP-4 and FABP-5 is closely associated with intrahepatic TG accumulation. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.